K-V Pharmaceutical Co 4
4 · K-V Pharmaceutical Co · Filed Nov 20, 2013
Insider Transaction Report
Form 4
Silver Point Capital L.P.
10% Owner
Transactions
- Purchase
Common Stock
2013-11-18$46.50/sh+25,000$1,162,500→ 2,023,883 total
Footnotes (1)
- [F1]Silver Point Capital, L.P. ("Silver Point") is the investment manager of Silver Point Capital Fund, L.P. and Silver Point Capital Offshore Fund, Ltd. (the "Funds") and, by reason of such status, may be deemed to be the beneficial owner of all of the reported securities held by the Funds. Silver Point Capital Management, LLC ("Management") is the general partner of Silver Point and as a result may be deemed to be the beneficial owner of all securities held by the Funds. Messrs. Edward A. Mule and Robert J. O'Shea are each members of Management and as a result may be deemed to be the beneficial owner of all of the securities held by the Funds. Silver Point, Management and Messrs. Mule and O'Shea disclaim beneficial ownership of the reported securities held by the Funds except to the extent of their pecuniary interests.